Exenatide Attenuates Non-Alcoholic Steatohepatitis by Inhibiting the Pyroptosis Signaling Pathway

BACKGROUND/AIMS: Exenatide is a glucagon-like polypeptide-1 analog, whose main clinical use is to treat type 2 diabetes. However, the mechanism of exenatide in mitigating non-alcoholic steatohepatitis (NASH) remains unclear. This study aimed to investigate the in vitro and in vivo effect of exenatid...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yu, Wang, Da-Wei, Wang, Dan, Duan, Bin-Hong, Kuang, Hong-Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092357/
https://www.ncbi.nlm.nih.gov/pubmed/33953700
http://dx.doi.org/10.3389/fendo.2021.663039

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092357/
https://www.ncbi.nlm.nih.gov/pubmed/33953700
http://dx.doi.org/10.3389/fendo.2021.663039

Ejemplares similares